2,455 Shares in DocuSign, Inc. (NASDAQ:DOCU) Acquired by Telos Capital Management Inc.

Telos Capital Management Inc. bought a new stake in DocuSign, Inc. (NASDAQ:DOCU) during the fourth quarter, Holdings Channel.com reports. The fund bought 2,455 shares of the company’s stock, valued at approximately $221,000.

Several other hedge funds have also bought and sold shares of DOCU. State Street Corp raised its position in shares of DocuSign by 2.3% during the 3rd quarter. State Street Corp now owns 5,372,939 shares of the company’s stock valued at $333,604,000 after buying an additional 120,743 shares in the last quarter. Geode Capital Management LLC raised its position in DocuSign by 1.6% during the third quarter. Geode Capital Management LLC now owns 3,483,184 shares of the company’s stock valued at $215,789,000 after purchasing an additional 53,554 shares in the last quarter. Thrivent Financial for Lutherans lifted its stake in DocuSign by 5.2% during the third quarter. Thrivent Financial for Lutherans now owns 2,277,312 shares of the company’s stock worth $141,398,000 after purchasing an additional 112,919 shares during the last quarter. FMR LLC boosted its holdings in shares of DocuSign by 16.8% in the 3rd quarter. FMR LLC now owns 2,192,885 shares of the company’s stock worth $136,156,000 after purchasing an additional 315,073 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in shares of DocuSign by 14.4% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,659,367 shares of the company’s stock valued at $103,030,000 after purchasing an additional 208,813 shares during the last quarter. 77.64% of the stock is currently owned by institutional investors.

DocuSign Price Performance

Shares of NASDAQ:DOCU opened at $90.48 on Friday. DocuSign, Inc. has a 1 year low of $48.70 and a 1 year high of $107.86. The stock’s 50-day moving average is $92.36 and its 200 day moving average is $73.96. The company has a market cap of $18.28 billion, a PE ratio of 18.66, a P/E/G ratio of 8.74 and a beta of 0.89.

Insider Activity

In other news, CFO Blake Jeffrey Grayson sold 15,588 shares of DocuSign stock in a transaction dated Wednesday, December 18th. The shares were sold at an average price of $97.78, for a total transaction of $1,524,194.64. Following the sale, the chief financial officer now owns 85,851 shares of the company’s stock, valued at approximately $8,394,510.78. The trade was a 15.37 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Allan C. Thygesen sold 7,763 shares of the stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $80.54, for a total transaction of $625,232.02. Following the completion of the transaction, the chief executive officer now directly owns 100,062 shares of the company’s stock, valued at approximately $8,058,993.48. The trade was a 7.20 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 685,773 shares of company stock valued at $66,032,726. Company insiders own 1.66% of the company’s stock.

Wall Street Analyst Weigh In

DOCU has been the subject of a number of recent research reports. UBS Group boosted their target price on DocuSign from $60.00 to $100.00 and gave the stock a “neutral” rating in a research report on Friday, December 6th. Hsbc Global Res upgraded shares of DocuSign to a “moderate sell” rating in a report on Friday, December 6th. Morgan Stanley increased their target price on shares of DocuSign from $62.00 to $97.00 and gave the company an “equal weight” rating in a report on Friday, December 6th. Robert W. Baird boosted their price target on shares of DocuSign from $59.00 to $100.00 and gave the stock a “neutral” rating in a research note on Friday, December 6th. Finally, JMP Securities reaffirmed a “market outperform” rating and set a $124.00 price objective on shares of DocuSign in a research note on Tuesday, January 7th. Three investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $92.45.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.